E-LIB Suche - Ergebnisse für: Fayette, Jerome

1

Uncovering immune checkpoint heterogeneity in oral squamous..:

Le Meitour, Yannick ; Foy, Jean-Philippe ; Guinand, Mathilde...
Oral Oncology. 149 (2024) - p. 106680 , 2024

Link: https://doi.org/10.1016/..

2

La cancérologie en Guyane : un défi à gagner:

Droz, Jean-Pierre ; Couppié, Pierre ; Fayette, Jérôme
Bulletin du Cancer. 111 (2024) 6 - p. 597-607 , 2024

Link: https://doi.org/10.1016/..

3

Outcomes in biomarker-selected subgroups from the KESTREL s..:

Seiwert, Tanguy Y. ; Wildsmith, Sophie ; Fayette, Jérôme...
Cancer Immunology, Immunotherapy. 73 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

4

Adapted EXTREME regimen in the first-line treatment of fit,..:

Guigay, Joël ; Le Caer, Hervé ; Ferrand, François-Régis...
The Lancet Healthy Longevity. 5 (2024) 6 - p. e392-e405 , 2024

Link: https://doi.org/10.1016/..

5

Survival of bronchopulmonary cancers according to radon exp..:

Dessemon, Juliette ; Perol, Olivia ; Chauvel, Cécile...
Frontiers in Public Health. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

6

Cetuximab versus methotrexate in first-line treatment of ol..:

Guigay, Joël ; Ortholan, Cécile ; Vansteene, Damien...
The Lancet Healthy Longevity. 5 (2024) 3 - p. e182-e193 , 2024

Link: https://doi.org/10.1016/..

7

NISCAHN: a phase II trial of nivolumab in patients with sal..:

Fayette, Jérôme ; Even, Caroline ; Digue, Laurence...
BMJ Oncology. 2 (2023) 1 - p. e000065 , 2023

Link: https://doi.org/10.1136/..

8

Occupational asbestos exposure and survival among lung canc..:

Noelle, Hugo ; Pérol, Olivia ; Pérol, Maurice...
Lung Cancer. 179 (2023) - p. 107182 , 2023

Link: https://doi.org/10.1016/..

9

CTIM-32. A PARALLEL COHORT PHASE 2 STUDY OF REGORAFENIB PLU..:

Simonelli, Matteo ; Caccese, Mario ; Larrieu-Ciron, Delphine...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v69-v70 , 2023

Link: https://doi.org/10.1093/..

10

Efficacy of second-line chemotherapy or immune checkpoint i..:

Vienne, Agathe ; Collet, Laetitia ; Chevalier, Thomas...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

11

Tumor Mutational Burden as a Predictor of Survival with Dur..:

Wildsmith, Sophie ; Li, Weimin ; Wu, Song...
Clinical Cancer Research. 29 (2023) 11 - p. 2066-2074 , 2023

Link: https://doi.org/10.1158/..

12

Comparison between exclusive (chemo)radiation and surgery o..:

Gauduchon, Coauthor(s) Thibault ; Dalban, Cécile ; Philippe, Zrounba...
Oral Oncology Reports. 6 (2023) - p. 100042 , 2023

Link: https://doi.org/10.1016/..

13

Randomized phase II study of preoperative afatinib in untre..:

Marret, Grégoire ; Temam, Stéphane ; Kamal, Maud...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

MEK1/2 inhibition transiently alters the tumor immune micro..:

Prasad, Manu ; Zorea, Jonathan ; Jagadeeshan, Sankar...
Journal for ImmunoTherapy of Cancer. 10 (2022) 3 - p. e003917 , 2022

Link: https://doi.org/10.1136/..

15

Benefit from adjuvant radiotherapy according to the number ..:

Pêtre, Adeline ; Pommier, Pascal ; Brahmi, Tristan...
Radiotherapy and Oncology. 168 (2022) - p. 53-60 , 2022

Link: https://doi.org/10.1016/..